Back
Sinopharm Group Co., Ltd. 10K Form
Sell
47
SHTDF
Sinopharm Group Co., Ltd.
Last Price:
$2.68
Seasonality Move:
-5.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SHTDF News And Ratings
See the #1 stock for the next 7 days that we like better than SHTDF
SHTDF Financial Statistics
Sales & Book Value
| Annual Sales: | $80B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 32.59 |
| Annual Sales: | $3.46 |
| Price / Book: | 0.69 |
Profitability
| EPS (TTM): | 0.31910 |
|---|---|
| Net Income (TTM): | $1.5B |
| Gross Margin: | $5.7B |
| Return on Equity: | 5.75% |
| Return on Assets: | 1.76% |
Sinopharm Group Co., Ltd. Earnings Forecast
Key Sinopharm Group Co., Ltd. Financial Ratios
-
The Gross Profit Margin over the past 20 years for SHTDF is 7.17%.
-
The Selling, General & Administrative Expenses for SHTDF have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 23.03% of Operating Income.
-
The Net Earning history of SHTDF is 1.88% of Total Revenues.
-
Per Share Earnings over the last 20 years have been positive in 18 years.
Sinopharm Group Co., Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | SHTDF |
| Website: | ir.sinopharmgroup.com.cn |
Debt
| Debt-to-Equity Ratio: | 0.9 |
|---|---|
| Current Ratio: | 1.39 |
| Quick Ratio: | 1.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.39 |
|---|---|
| Forward P/E Ratio: | 0 |
SHTDF Technical Analysis vs Fundamental Analysis
Sell
47
Sinopharm Group Co., Ltd. (SHTDF)
is a Sell
Is Sinopharm Group Co., Ltd. a Buy or a Sell?
-
Sinopharm Group Co., Ltd. stock is rated a SellThe current Sinopharm Group Co., Ltd. [SHTDF] share price is $2.68. The Score for SHTDF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.